← Leaderboards
Oluwademilade Nuga
Wayne State University
$117,772
Attributed
$117,772
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $43.8K · FY2020–22$50K$37.5K$25K$12.5K$0
'20
'21
'22
Funding mix
By agency
NIH$117,772 · 1
By mechanism
F31$117,772 · 1
Top collaborators
No co-investigators on record.
Most similar at Wayne State University
Same institution · by research overlap
- Cornelis Johan Elferink$17,242,434
- Anthony Frank Shields$10,178,885
- Aleem Gangjee$13,765,845
- Hyeong-Reh Choi Kim$17,738,970
- Adrianne Wallace-Povirk$234,484
Others in their field
Other Emerging Leaders on “Adult”
- Beth Baseler · Leidos Biomedical Research, Inc.$127,607,354
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$93,592,175
- Susan M Landau · University Of California Berkeley$47,252,026
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$42,295,422
- Nancy Roche · Leidos Biomedical Research, Inc.$39,999,252
- Evan Z Macosko · Broad Institute, Inc.$32,116,761
Research focus
AdultAffectAutomobile DrivingBaseBioinformaticsBrainBreast Cancer TreatmentCancer PatientCancer Stem CellCancer TypeCdk4 GeneCdkn2a GeneCell CycleCell Cycle DeregulationCell Cycle ProteinsCell DivisionCell LineCellsCell SurvivalChemotherapyClinical TrialsCodeCohortAcute
Grant awards (3)
Cyclin Dependent Kinase 4/6 (CDK4/6) as a Therapeutic Target in Glioblastoma$30,752
F31 · FY2022 · CA · contact PI
Cyclin Dependent Kinase 4/6 (CDK4/6) as a Therapeutic Target in Glioblastoma$43,768
F31 · FY2021 · CA · contact PI
Cyclin Dependent Kinase 4/6 (CDK4/6) as a Therapeutic Target in Glioblastoma$43,252
F31 · FY2020 · CA · contact PI